JBA (Japanese Bioindustry Association) survey shows growing bioindustry:
This article was originally published in Clinica
A survey conducted recently by the Japanese Bioindustry Association (JBA) showed that 30 bioventures were established in Japan in 2002, bringing the total number in existence there to 333. Having tracked the trend, the authorities established the Biotechnology Strategy Council, but also see the need to improve the infrastructure to develop the bioindustry sector fully. Part of their efforts will be seen later this year, with the launch of Focus 21, a programme that will help to commercialise R&D achievements. One spin-off will be the development of a ¥00bn ($2.5bn) market for health management, equipment and services.